ELRANATAMAB
Elranatamab 44 mg/1.1 mL injection, 1.1 mL vial
ELRANATAMAB (15301H)
15301H
Manner of administration:Injection
Restriction
Indication: Relapsed or refractory multiple myeloma
Treatment phase: Induction treatment (step-up dosing)
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 1 | # of repeats: 1 | DPMQ: $3,496.00 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Elrexfio | |||||